400 related articles for article (PubMed ID: 29940854)
21. Polyclonal activation of naïve T cells by urease deficient-recombinant BCG that produced protein complex composed of heat shock protein 70, CysO and major membrane protein-II.
Tsukamoto Y; Maeda Y; Tamura T; Mukai T; Makino M
BMC Infect Dis; 2014 Apr; 14():179. PubMed ID: 24690183
[TBL] [Abstract][Full Text] [Related]
22. Enhanced antigen-presenting activity and tumour necrosis factor-alpha-independent activation of dendritic cells following treatment with Mycobacterium bovis bacillus Calmette-Guérin.
Kim KD; Lee HG; Kim JK; Park SN; Choe IS; Choe YK; Kim SJ; Lee E; Lim JS
Immunology; 1999 Aug; 97(4):626-33. PubMed ID: 10457216
[TBL] [Abstract][Full Text] [Related]
23. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
24. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
[TBL] [Abstract][Full Text] [Related]
25. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity.
Jiao X; Lo-Man R; Guermonprez P; Fiette L; Dériaud E; Burgaud S; Gicquel B; Winter N; Leclerc C
J Immunol; 2002 Feb; 168(3):1294-301. PubMed ID: 11801668
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules.
Majlessi L; Combaluzier B; Albrecht I; Garcia JE; Nouze C; Pieters J; Leclerc C
J Immunol; 2007 Aug; 179(3):1825-33. PubMed ID: 17641049
[TBL] [Abstract][Full Text] [Related]
28. Cutting edge: Nicastrin and related components of γ-secretase generate a peptide epitope facilitating immune recognition of intracellular mycobacteria, through MHC class II-dependent priming of T cells.
Singh CR; Bakhru P; Khan A; Li QB; Jagannath C
J Immunol; 2011 Dec; 187(11):5495-9. PubMed ID: 22039303
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
30. Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.
Denis O; Lozes E; Huygen K
Infect Immun; 1997 Feb; 65(2):676-84. PubMed ID: 9009330
[TBL] [Abstract][Full Text] [Related]
31. Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.
Pérez de Val B; Villarreal-Ramos B; Nofrarías M; López-Soria S; Romera N; Singh M; Abad FX; Xing Z; Vordermeier HM; Domingo M
Clin Vaccine Immunol; 2012 Sep; 19(9):1339-47. PubMed ID: 22761299
[TBL] [Abstract][Full Text] [Related]
32. A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guérin).
Russell MS; Iskandar M; Mykytczuk OL; Nash JH; Krishnan L; Sad S
J Immunol; 2007 Jul; 179(1):211-20. PubMed ID: 17579040
[TBL] [Abstract][Full Text] [Related]
33. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
34. Deletion of BCG Hip1 protease enhances dendritic cell and CD4 T cell responses.
Bizzell E; Sia JK; Quezada M; Enriquez A; Georgieva M; Rengarajan J
J Leukoc Biol; 2018 Apr; 103(4):739-748. PubMed ID: 29345365
[TBL] [Abstract][Full Text] [Related]
35. Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin.
Hope JC; Guzman E; Cubillos-Zapata C; Stephens SA; Gilbert SC; Prentice H; Sopp P; Howard CJ; Charleston B
Vaccine; 2012 Mar; 30(13):2357-67. PubMed ID: 22281103
[TBL] [Abstract][Full Text] [Related]
36. A novel dendritic cell-targeted lentiviral vector, encoding Ag85A-ESAT6 fusion gene of Mycobacterium tuberculosis, could elicit potent cell-mediated immune responses in mice.
Shakouri M; Moazzeni SM; Ghanei M; Arashkia A; Etemadzadeh MH; Azadmanesh K
Mol Immunol; 2016 Jul; 75():101-11. PubMed ID: 27267270
[TBL] [Abstract][Full Text] [Related]
37. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations.
Whelan AO; Wright DC; Chambers MA; Singh M; Hewinson RG; Vordermeier HM
Vaccine; 2008 Jan; 26(2):166-73. PubMed ID: 18055073
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope.
Feng CG; Demangel C; Kamath AT; Macdonald M; Britton WJ
Int Immunol; 2001 Apr; 13(4):451-8. PubMed ID: 11282984
[TBL] [Abstract][Full Text] [Related]
39. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo.
Wolf AJ; Linas B; Trevejo-Nuñez GJ; Kincaid E; Tamura T; Takatsu K; Ernst JD
J Immunol; 2007 Aug; 179(4):2509-19. PubMed ID: 17675513
[TBL] [Abstract][Full Text] [Related]
40. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner.
Chatterjee S; Dwivedi VP; Singh Y; Siddiqui I; Sharma P; Van Kaer L; Chattopadhyay D; Das G
PLoS Pathog; 2011 Nov; 7(11):e1002378. PubMed ID: 22102818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
